Advertisement
  • Reuters

    Geron shares surge after U.S. FDA approves blood disorder drug

    The drug, which will be sold under the brand Rytelo, will compete with Bristol Myers Squibb's Reblozyl to treat transfusion-dependent anemia in patients with myelodysplastic syndromes - a group of blood cancers where blood cells in the bone marrow do not mature or become healthy blood cells. Geron said it will give information on the new drug's pricing and availability in a conference call with investors later in the day. In March, the independent advisers to the FDA backed the benefits of the drug, saying it outweighed its risks.

  • Reuters

    Microsoft to double down on Game Pass at Xbox showcase with 'Call of Duty' title

    Microsoft's Xbox Game Pass will take center stage at its annual video-game showcase on Sunday, as the software giant prepares to roll out the latest installment in its best-selling "Call of Duty" franchise on the subscription service. Putting the title on Game Pass would mark a major bet by Microsoft on the nascent service at a time when its videogame business has been grappling with tough competition from Sony's PlayStation consoles and a broader slowdown in the industry. The move will likely boost growth of the subscription service that had 34 million subscribers as of February.

  • Cosmo

    How rich are the new Real Housewives of New York cast?

    Wondering how rich the cast of 'RHONY' is? Check out Sai De Silva, Ubah Hassan, Erin Dana Lichy, Jenna Lyons, Jessel Taank and Brynn Whitfield's net worths.